Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)

NCT06467344 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Stargardt Disease
Cone Rod Dystrophy
Juvenile Macular Degeneration
Stargardt Disease 1

Interventions

DRUG: ACDN-01

Sponsor

Ascidian Therapeutics, Inc